IPOGrid
Daily Spotlight · October 10, 2026
TRex Bio's $116.7 Million IPO Finds a Floor at $14
TRex Bio clears its IPO at $14, with Lilly support and no first-day premium
By Erik Aronesty · TRex Bio, Inc.
Lilly's indicated interest and five bookrunners helped TRex Bio preserve its full share count, but low-end pricing and a flat debut leave the next rerating to clinical data. By Erik Aronesty SOUTH SAN FRANCISCO, Calif., October 10, 2026 TRex Bio reached the...
Read by 900+ subscribers, 300+ of them at hedge funds.
IPOGrid Weekly · October 5, 2026 – October 11, 2026
Biotech IPOs cleared the calendar, then met a selective market
TRex held its offer price as Retension slipped
By Erik Aronesty · October 12, 2026
Weekly review: October 5 to October 11, 2026 Two clinical-stage biotechs completed U.S. IPOs on the same night, but the market delivered two very different verdicts. TRex Bio raised $116.7 million at the bottom of its range and finished its first session at...
Read by 900+ subscribers, 300+ of them at hedge funds.
IPO Calendar
Deals on the board
| Company | Deal | Status | Signal | Price | Gross Proceeds | Lead Underwriter | Exchange | Latest Form | Last Filing |
|---|---|---|---|---|---|---|---|---|---|
| ipo | amended | Watch | $16.00 | $150,000,000 | J.P. Morgan | Nasdaq Global Select Market | S-1/A | 2026-10-08 | |
|
Oura Inc.
OURA
|
ipo | amended | Watch | $40.00 to $44.00 | $2,100,000,000 | Goldman Sachs & Co. LLC | Nasdaq Global Select Market | FWP | 2026-09-24 |
| ipo | amended | Watch | $4.00 | $25,000,000 | ARC Group Securities LLC | Nasdaq Capital Market | F-1/A | 2026-09-29 | |
| ipo | amended | Watch | $11.00 | $42,900,000 | Kingswood Capital Partners, LLC | Nasdaq | F-1/A | 2026-09-24 | |
| ipo | amended | Watch | $4.50 | $18,000,000 | Alexander Capital, L.P. | NYSE American | S-1/A | 2026-09-30 | |
| ipo | amended | Active | $20.00 | $50,000,000 | WallachBeth Capital LLC | Nasdaq | S-1 | 2026-10-09 | |
|
AM PM Group Ltd
AMPM
|
ipo | amended | Active | $4.50 | $33,750,000 | Prime Number Capital LLC | Nasdaq Global Market | F-1/A | 2026-09-17 |
|
Amaero Inc.
AMRO
|
ipo | amended | Active | $5.15 | $19,983,496 | - | Nasdaq | S-1/A | 2026-10-08 |
|
Tracx Logis Ltd.
TRCX
|
ipo | amended | Active | $20.00 | $30,000,000 | Roth Capital Partners | Nasdaq Global Market | F-1/A | 2026-10-08 |
|
Star Integratia Ltd
ITIA
|
ipo | amended | Active | $7.00 | $29,166,669 | EDDID SECURITIES USA INC. | Nasdaq Capital Market | F-1/A | 2026-09-17 |
| ipo | amended | Active | $1.00 | $1,000,000 | self_underwritten | Nasdaq | F-1/A | 2026-10-09 | |
|
Silentium Ltd.
SIAI
|
ipo | amended | Active | $7.00 | $15,050,000 | ThinkEquity | NYSE American | F-1/A | 2026-10-06 |
See full grid
Showing 12 exchange-focused names from 170 active public IPO issuers.
Active Signals
IPO filing and listing signals
Iambic Therapeutics, Inc.
IAM
$60M anchor demand
ARK Investment Management LLC and Duquesne Family Office LLC expressed indication of interest to purchase up to $60.0 million in shares at IPO price
Anchor interest from ARK Investment Management LLC and Duquesne Family Office LLC · $60M cornerstone indication · Cover banks: J.P. Morgan Securities LLC, Jefferies LLC, BofA Securities, Inc. +1 · Financial texture: Collaboration revenue $12,753
Forgent Power Solutions, Inc.
FPS
86% revenue growth
Revenues for the nine months ended March 31, 2026 were $958.4 million as compared to $515.6 million for the nine months ended March 31, 2025.
Cover banks: Goldman Sachs & Co. LLC, Jefferies LLC, Morgan Stanley & Co. LLC · Financial texture: Revenues for the nine months ended March 31, 2026 were $958.4 million as compared to $515.6 million for the nine months ended March 31, 2025.
Oura Inc.
OURA
Named anchor interest
Eli Lilly and Company indicated interest in $100.0M and Dragoneer Investment Group, LLC in $300.0M
Anchor interest from Eli Lilly and Company and Dragoneer Investment Group, LLC · Financial texture: Deterministic scale normalization applied to revenuePrior1, revenuePrior2, adjustedEbitdaCurrent, adjustedEbitdaPrior1, adjustedEbitdaPrior2,... · Deal terms: 14M shares · $0 price · $2.1B deal · Nasdaq OURA
Columbia Financial, Inc./MD/
CLBK
Operating company numbers
Total consolidated revenues $266,046 for 2025
Cover banks: Keefe, Bruyette & Woods, Inc. · Financial texture: Total consolidated revenues $266,046 for 2025 · Deal terms: 52M shares · $10 price · $1.9B deal · Timing: We anticipate simultaneously completing the conversion, the offering and the Northfield Bancorp acquisition...
POP GLOBAL ACQUISITION Ltd
Named anchor interest
The Sponsor has committed to purchase private placement units, and Kingswood Capital Partners, LLC received representative shares as underwriting...
Anchor interest from Kingswood Capital Partners, LLC · $2.1M private placement from Sponsor · Cover banks: KINGSWOOD CAPITAL PARTNERS, LLC · Financial texture: Cash flows from operating activities: Net loss $ (15,000)
Timwood Holdings Ltd
TIWD
8.4% revenue growth
Revenue 4,287,965
Cover banks: Kingswood Capital Partners, LLC · Financial texture: Revenue 4,287,965 · Deal terms: 5.6M shares · $4-$6 · $36M deal · Nasdaq Capital Market TIWD · Timing: Approximate date of commencement of proposed sale to the public: As soon as practicable after this...